follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeAuthorsSiraj Sarwar

      Articles by Siraj Sarwar

      Siraj Sarwar
      Based in Saudi Arabia, Siraj has a strong understanding of and passion for accounting and finance. He has worked for international clients for many years on several projects related to the stock market, equity research and other business, accounting and finance related projects. Siraj is a published financial analyst on the world's leading websites including SeekingAlpha, TheStreet, MSN, and others.
      LinkedIn
      Agriculture

      Arcadia Biosciences Improving Fundamentals are Driving its Shares Higher

      Jan 24 Siraj Sarwar
      Arcadia Biosciences Inc (NASDAQ:RKDA) continues to generate the huge movements in its stock price, allowing investors to create profit-making opportunities. Following a huge selloff in the last two years, Arcadia stock started gaining momentum over ... [Read]
      Zymeworks Inc
      Biotechnology

      Zymeworks Inc. Stock Soars; Here’s What to Expect

      Jan 23 Siraj Sarwar
      After declining sharply in the mid of the last year, Zymeworks Inc. (TSX:ZYME) (NASDAQ:ZYME) shares bounced back significantly last month, thanks to strong results related to its Phase 1 dose-escalation study. ZYME stock gained more ... [Read]
      Fate therapeutics
      Biotechnology

      Bullish Sentiments are Rising for Fate Therapeutics Stock Price

      Jan 23 Siraj Sarwar
      Fate Therapeutics Inc. (NASDAQ:FATE) shares continue to extend the momentum in Tuesday trade, supported by investors bullish bets on its future fundamentals and advancement in key pipeline products. Fate Therapeutics shares improved 14% in Tuesday’s ... [Read]
      Revolution Lighting Technologies
      Computer Hardware

      Revolution Lighting Technologies Shares Soar Amid Higher Price Targets

      Jan 23 Siraj Sarwar
      Revolution Lighting Technologies (NASDAQ:RVLT) shares bounced back significantly in Tuesday trade following the price target upgrade from Thomson Reuters. According to reports, Thomson Reuters has increased RVLT stock price target to above $6.50 a share, ... [Read]
      Drug Manufacturers

      Sorrento Therapeutics Higher on Bullish Reports

      Jan 22 Siraj Sarwar
      Sorrento Therapeutics (NASDAQ:SRNE) shares are rallying over the last three months, thanks to the company’s smart business strategies and advancements in its pipeline. Its shares spiked more than 20% in Monday trade and its volume ... [Read]
      StarTek
      Business Services

      Is StarTek Ready to Bounce Back?

      Jan 22 Siraj Sarwar
      After hitting the highest level of $14.78 per share in the mid of the last year, StarTek (NASDAQ:SRT) shares plunged in the second half, driven by lower than expected financial results. The $166 million company ... [Read]
      Business Services

      Lightbridge Corp Stock Flies Higher After Patent Approval

      Jan 22 Siraj Sarwar
      Lightbridge Corp (NASDAQ:LTBR) shares rallied as much as 90% in Monday’s trade after receiving approval for the key patent of the innovative fuel design. Before the latest rally, its shares were trading in a narrow ... [Read]
      Bullish Bets Soar on GNC Holdings
      Consumer

      Bullish Bets Soar on GNC Holdings After Earnings Guidance

      Jan 19 Siraj Sarwar
      After the massive rally of more than 46% in Thursday trade, GNC Holdings (NYSE:GNC) shares are down almost 9% in Friday trading. GNC stock currently trades just below $5 a share with a market capitalization of ... [Read]
      Higher Volume Supports Sientra Stock
      Health

      Analysts Upgrades and Higher Volume Supports Sientra Stock

      Jan 19 Siraj Sarwar
      Sientra, Inc. (NASDAQ:SIEN) stock price gained 16% during Friday trading, thanks to a strong growth in volume and higher price targets. Volumes are important for the stock, as stock price usually moves up with the ... [Read]
      Electro Scientific Industries Extends the Rally
      Computer Hardware

      Electro Scientific Industries Extends the Rally, Shares up 243% in Twelve Months

      Jan 18 Siraj Sarwar
      Electro Scientific Industries (NASDAQ:ESIO) shares are moving sharply higher since the start of 2017. ESIO stock gained 243% in the last twelve months, supported by its improving financial numbers. Its stock soared more than 20% ... [Read]

      Posts pagination

      « 1 … 27 28 29 … 31 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE Arcadia Biosciences Inc. Email Alerts
      Get FREE Arcadia Biosciences Inc. Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x